Heska Corp. (NASDAQ:HSKA) was up 1% during trading on Wednesday . The company traded as high as $51.37 and last traded at $51.03, with a volume of 66,707 shares trading hands. The stock had previously closed at $50.54.

A number of equities research analysts have recently commented on HSKA shares. TheStreet raised shares of Heska Corp. from a “hold” rating to a “buy” rating in a report on Wednesday, May 25th. Zacks Investment Research cut shares of Heska Corp. from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 5th. Gabelli cut shares of Heska Corp. from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Sidoti started coverage on shares of Heska Corp. in a report on Friday, July 1st. They issued a “buy” rating and a $49.00 target price for the company. Finally, B. Riley reaffirmed a “buy” rating and issued a $52.50 target price on shares of Heska Corp. in a report on Saturday, August 6th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $52.83.

The stock has a market capitalization of $349.94 million and a PE ratio of 51.57. The stock has a 50-day moving average of $45.06 and a 200-day moving average of $35.97.

Heska Corp. (NASDAQ:HSKA) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $0.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.17. The firm had revenue of $30 million for the quarter, compared to analysts’ expectations of $28.47 million. The firm’s revenue for the quarter was up 25.5% on a year-over-year basis. Equities analysts predict that Heska Corp. will post $1.11 EPS for the current fiscal year.

In other Heska Corp. news, CEO Kevin S. Wilson sold 14,040 shares of the firm’s stock in a transaction on Friday, July 1st. The shares were sold at an average price of $38.94, for a total transaction of $546,717.60. Following the completion of the transaction, the chief executive officer now directly owns 165,960 shares of the company’s stock, valued at approximately $6,462,482.40. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Kevin S. Wilson sold 5,960 shares of the firm’s stock in a transaction on Wednesday, July 6th. The stock was sold at an average price of $40.27, for a total transaction of $240,009.20. Following the transaction, the chief executive officer now directly owns 160,000 shares of the company’s stock, valued at $6,443,200. The disclosure for this sale can be found here.

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.